Apria Announces Launch of Secondary Offering of Common Stock
Apria announced a secondary offering of 4,500,000 shares of common stock, initiated by a selling stockholder affiliated with Blackstone. Additionally, the underwriters may purchase up to 675,000 additional shares. Importantly, Apria is not offering any shares nor will it receive proceeds from this sale. The offering's management is led by Citigroup and Goldman Sachs with Citizens Capital Markets as a co-manager. A preliminary prospectus has been filed but has not yet become effective. This press release is not an offer to sell or buy securities.
- The secondary offering presents liquidity options for existing shareholders.
- No proceeds will be received by Apria from the offering, which may limit future investment capacity.
INDIANAPOLIS, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR) announced today that a selling stockholder affiliated with Blackstone has commenced a secondary offering of 4,500,000 shares of Apria common stock. In connection with the offering, the selling stockholder intends to grant the underwriters a 30-day option to purchase up to an additional 675,000 shares of common stock.
Apria is not offering any shares of its common stock and will not receive any net proceeds from the sale of common stock by the selling stockholder. Citigroup and Goldman Sachs & Co. LLC are acting as joint lead book-running managers for the offering. Citizens Capital Markets is acting as a co-manager for the offering.
The offering of these securities will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to the offering may be obtained from: Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-800-831-9146 or by email at prospectus@citi.com or Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at 1-866-471-2526, by facsimile at 1-212-902-9316 or by email at prospectus-ny@ny.email.gs.com.
A registration statement, including a prospectus, which is preliminary and subject to completion, relating to these securities has been filed with the Securities and Exchange Commission (the “SEC”), but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time that the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Apria
Apria is a leading provider of integrated home healthcare equipment and related services in the United States, providing home respiratory therapy, obstructive sleep apnea treatment and negative pressure wound therapy. Its approximately 280 locations throughout the continental United States and Hawaii serve nearly 2 million patients each year. All of Apria’s locations are accredited by The Joint Commission.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include any statements regarding the proposed offering of Apria common stock and other non-historical statements. Forward-looking statements include all statements that do not relate solely to historical or current facts. In some cases, you can identify these forward-looking statements by the use of words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “could,” “seeks,” “predicts,” “intends,” “trends,” “plans,” “estimates,” “anticipates” or the negative version of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors include but are not limited to those described under “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and in the Company’s Quarterly Report on Form 10-Q for the three months ended June 30, 2021, each as filed with the SEC, as such factors may be updated from time to time in the Company’s periodic filings with the SEC. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the Company’s filings with the SEC. Investors are urged to consider carefully the disclosure in the Company’s filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. The Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.
Investor Contacts
Kevin.Ellich@westwicke.com
Media Contacts
Mark.Corbae@westwicke.com
Kyle.Evans@westwicke.com
FAQ
What is the size of the secondary offering by Apria?
Who is managing the secondary offering for Apria?
Will Apria receive proceeds from the stock offering?
When will the registration statement for Apria's offering become effective?
